{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:33:08Z","timestamp":1794432788334,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Remimazolam besylate is a newer benzodiazepine with characteristics of quick onset of effects, short maintenance and recovery times without accumulation in tissues. This trial was conducted to confirm the efficacy and safety of remimazolam besylate versus propofol during hysteroscopy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Patients undergoing hysteroscopy were randomly assigned to either the remimazolam (Group R) or the propofol group (Group P). Group R was administered an induction dose of 0.2\u2009mg\/kg and a maintenance dosage of 1.0\u2009mg\/kg\/h. In Group P, propofol was started at 1.5\u20132.0\u2009mg\/kg and then maintained at 3.0\u20136.0\u2009mg\/kg\/h. After remimazolam besylate or propofol induction, remifentanil was infused using a target-controlled infusion system with a target concentration of 1.5\u2009ng\/ml and titrated during the procedure. The incidence rates of injection pain, low oxygen saturation (SpO\n                      <jats:sub>2<\/jats:sub>\n                      ) and adverse effects in both groups were compared.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eighty-two patients were included in this study. The incidence of adverse events in Group R (3.7%) was significantly lower than that in Group P (36.6%) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The incidence of injection pain in Group P (80.5%) was much higher than that in Group R (2.4%) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The incidence of other adverse events, such as low SpO\n                      <jats:sub>2<\/jats:sub>\n                      , bradycardia, and hypotension in Group R was lower than that in Group P (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Remimazolam besylate proves to be a safer alternative for anesthesia during hysteroscopy. Moreover, adverse events caused by propofol, such as low SpO\n                      <jats:sub>2<\/jats:sub>\n                      and injection pain, are largely avoided.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      This study was approved by the Clinical Research Ethics Committee of Mengcheng County No. 1 People\u2019s Hospital (2020MYL20003) and registered at\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\">http:\/\/www.chictr.org.cn<\/jats:ext-link>\n                      (15\/09\/2020,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/edit.aspx?pid=61430&amp;htm=4\">ChiCTR-2000038252<\/jats:ext-link>\n                      ). The study protocol followed the CONSORT guidelines. The study protocol was performed in the relevant guidelines.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12871-021-01373-y","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T03:18:57Z","timestamp":1621480737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":154,"title":["Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial"],"prefix":"10.1186","volume":"21","author":[{"given":"Xiaoqiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"issue":"1","key":"1373_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bpobgyn.2005.10.002","volume":"20","author":"C Sutton","year":"2006","unstructured":"Sutton C. Hysteroscopic surgery. Best Pract Res Clin Obstet Gynaecol. 2006;20(1):105\u201337. https:\/\/doi.org\/10.1016\/j.bpobgyn.2005.10.002.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1373_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/IJWH.S98579","volume":"10","author":"S Kolhe","year":"2018","unstructured":"Kolhe S. Management of abnormal uterine bleeding - focus on ambulatory hysteroscopy. Int J Women's Health. 2018;10:127\u201336. https:\/\/doi.org\/10.2147\/IJWH.S98579.","journal-title":"Int J Women's Health"},{"issue":"2","key":"1373_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/jcpt.12793","volume":"44","author":"TB Tanriverdi","year":"2019","unstructured":"Tanriverdi TB, Koceroglu I, Devrim S, Gura CM. Comparison of sedation with dexmedetomidine vs propofol during hysteroscopic surgery: single-Centre randomized controlled trial. J Clin Pharm Ther. 2019;44(2):312\u20137. https:\/\/doi.org\/10.1111\/jcpt.12793.","journal-title":"J Clin Pharm Ther"},{"key":"1373_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jclinane.2016.06.023","volume":"38","author":"EE Moharram","year":"2017","unstructured":"Moharram EE, El Attar AM, Kamel MA. The impact of anesthesia on hemodynamic and volume changes in operative hysteroscopy: a bioimpedance randomized study. J Clin Anesth. 2017;38:59\u201367. https:\/\/doi.org\/10.1016\/j.jclinane.2016.06.023.","journal-title":"J Clin Anesth"},{"issue":"mar23 2","key":"1373_CR5","doi-asserted-by":"publisher","first-page":"c1130","DOI":"10.1136\/bmj.c1130","volume":"340","author":"N Cooper","year":"2010","unstructured":"Cooper N, Khan K, Clark T. Local anaesthesia for pain control during outpatient hysteroscopy: systematic review and meta-analysis. BMJ. 2010;340(mar23 2):c1130. https:\/\/doi.org\/10.1136\/bmj.c1130.","journal-title":"BMJ."},{"issue":"4","key":"1373_CR6","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/13697137.2020.1754388","volume":"23","author":"G Riemma","year":"2020","unstructured":"Riemma G, Schiattarella A, Colacurci N, Vitale SG, Cianci S, Cianci A, et al. Pharmacological and non-pharmacological pain relief for office hysteroscopy: an up-to-date review. Climacteric. 2020;23(4):376\u201383. https:\/\/doi.org\/10.1080\/13697137.2020.1754388.","journal-title":"Climacteric."},{"issue":"5","key":"1373_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/bcpt.13280","volume":"125","author":"J Yu","year":"2019","unstructured":"Yu J, Xiang B, Song Y, Chen H, Li Y, Liu C. ED50 of propofol in combination with low-dose sufentanil for intravenous anaesthesia in hysteroscopy. Basic Clin Pharmacol Toxicol. 2019;125(5):460\u20135. https:\/\/doi.org\/10.1111\/bcpt.13280.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"1373_CR8","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.gie.2015.08.062","volume":"83","author":"DJ Pambianco","year":"2016","unstructured":"Pambianco DJ, Borkett KM, Riff DS, Winkle PJ, Schwartz HI, Melson TI, et al. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2016;83(5):984\u201392. https:\/\/doi.org\/10.1016\/j.gie.2015.08.062.","journal-title":"Gastrointest Endosc"},{"key":"1373_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.gie.2018.04.2351","volume":"88","author":"DK Rex","year":"2018","unstructured":"Rex DK, Bhandari R, Desta T, DeMicco MP, Schaeffer C, Etzkorn K, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018;88:427\u201337 e6.","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"1373_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tgie.2016.02.004","volume":"18","author":"DJ Pambianco","year":"2016","unstructured":"Pambianco DJ, Cash BD. New horizons for sedation: the ultrashort acting benzodiazepine remimazolam. Tech Gastrointest Endosc. 2016;18(1):22\u20138. https:\/\/doi.org\/10.1016\/j.tgie.2016.02.004.","journal-title":"Tech Gastrointest Endosc"},{"issue":"3","key":"1373_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00228-019-02800-3","volume":"76","author":"XY Sheng","year":"2020","unstructured":"Sheng XY, Liang Y, Yang XY, Li LE, Ye X, Zhao X, et al. Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers. Eur J Clin Pharmacol. 2020;76(3):383\u201391. https:\/\/doi.org\/10.1007\/s00228-019-02800-3.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"1373_CR12","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00540-020-02788-6","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial. J Anesth. 2020;34(4):543\u201353. https:\/\/doi.org\/10.1007\/s00540-020-02788-6.","journal-title":"J Anesth"},{"issue":"4","key":"1373_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00004714-199008000-00003","volume":"10","author":"DA Chernik","year":"1990","unstructured":"Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, et al. Validity and reliability of the Observer\u2019s assessment of alertness\/sedation scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10(4):244\u201351.","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"1373_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s40265-020-01299-8","volume":"80","author":"SJ Keam","year":"2020","unstructured":"Keam SJ. Remimazolam: first approval. Drugs. 2020;80(6):625\u201333. https:\/\/doi.org\/10.1007\/s40265-020-01299-8.","journal-title":"Drugs."},{"issue":"5","key":"1373_CR15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jclinane.2007.12.015","volume":"20","author":"JH Ryu","year":"2008","unstructured":"Ryu JH, Kim JH, Park KS, Do SH. Remifentanil-propofol versus fentanyl-propofol for monitored anesthesia care during hysteroscopy. J Clin Anesth. 2008;20(5):328\u201332. https:\/\/doi.org\/10.1016\/j.jclinane.2007.12.015.","journal-title":"J Clin Anesth"},{"issue":"1","key":"1373_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/00000542-199701000-00004","volume":"86","author":"CF Minto","year":"1997","unstructured":"Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJ, Gambus PL, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I Model development. Anesthesiology. 1997;86(1):10\u201323. https:\/\/doi.org\/10.1097\/00000542-199701000-00004.","journal-title":"Anesthesiology"},{"key":"1373_CR17","doi-asserted-by":"crossref","unstructured":"Van Hese L, Theys T, Absalom AR, et al. Comparison of predicted and real propofol and remifentanil concentrations in plasma and brain tissue during target-controlled infusion: a prospective observational study. [J]. Anaesthesia. 2020;75:1626\u201334.","DOI":"10.1111\/anae.15125"},{"issue":"2","key":"1373_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/24754269.2017.1398000","volume":"1","author":"T Ye","year":"2017","unstructured":"Ye T, Yi Y. Sample size calculations in clinical research, third edition, by Shein-Chung chow, Jun Shao, Hansheng Wang, and Yuliya Lokhnygina. Stat Theory Relat Fields. 2017;1(2):265\u20136. https:\/\/doi.org\/10.1080\/24754269.2017.1398000.","journal-title":"Stat Theory Relat Fields"},{"issue":"8","key":"1373_CR19","first-page":"4594","volume":"12","author":"S Chen","year":"2020","unstructured":"Chen S, Wang J, Xu X, Huang Y, Xue S, Wu A, et al. The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase III clinical trial. Am J Transl Res. 2020;12(8):4594\u2013603.","journal-title":"Am J Transl Res"},{"issue":"1","key":"1373_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.chest.2018.09.015","volume":"155","author":"NJ Pastis","year":"2019","unstructured":"Pastis NJ, Yarmus LB, Schippers F, Ostroff R, Chen A, Akulian J, et al. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest. 2019;155(1):137\u201346. https:\/\/doi.org\/10.1016\/j.chest.2018.09.015.","journal-title":"Chest."},{"issue":"2","key":"1373_CR21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/jgh.15188","volume":"36","author":"SH Chen","year":"2020","unstructured":"Chen SH, Yuan TM, Zhang J, Bai H, Tian M, Pan CX, et al. Remimazolam tosilate in upper gastrointestinal endoscopy: a multicenter, randomized, non-inferiority, phase III trial. J Gastroenterol Hepatol. 2020;36(2):474\u201381. https:\/\/doi.org\/10.1111\/jgh.15188.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"1373_CR22","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/ALN.0000000000003103","volume":"132","author":"J Sch\u00fcttler","year":"2020","unstructured":"Sch\u00fcttler J, Eisenried A, Lerch M, Fechner J, Jeleazcov C, Ihmsen H. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. pharmacokinetics and clinical pharmacodynamics. Anesthesiology. 2020;132(4):636\u201351. https:\/\/doi.org\/10.1097\/ALN.0000000000003103.","journal-title":"Anesthesiology."},{"issue":"4","key":"1373_CR23","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.clinthera.2020.02.006","volume":"42","author":"X Chen","year":"2020","unstructured":"Chen X, Sang N, Song K, Zhong W, Wang H, Jiang J, et al. Psychomotor recovery following remimazolam-induced sedation and the effectiveness of flumazenil as an antidote. Clin Ther. 2020;42(4):614\u201324. https:\/\/doi.org\/10.1016\/j.clinthera.2020.02.006.","journal-title":"Clin Ther"},{"issue":"4","key":"1373_CR24","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/ACO.0000000000000877","volume":"33","author":"JR Sneyd","year":"2020","unstructured":"Sneyd JR, Rigby-Jones AE. Remimazolam for anaesthesia or sedation. Curr Opin Anaesthesiol. 2020;33(4):506\u201311. https:\/\/doi.org\/10.1097\/ACO.0000000000000877.","journal-title":"Curr Opin Anaesthesiol"},{"issue":"1","key":"1373_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/cpdd.797","volume":"10","author":"K Hu","year":"2021","unstructured":"Hu K, Xiang Q, Wang Z, Sheng X, Li L, Liang Y, et al. Effects of vitamin D receptor, cytochrome P450 3A, and cytochrome P450 oxidoreductase genetic polymorphisms on the pharmacokinetics of remimazolam in healthy Chinese volunteers. Clin Pharmacol Drug Dev. 2021;10(1):22\u20139. https:\/\/doi.org\/10.1002\/cpdd.797.","journal-title":"Clin Pharmacol Drug Dev"}],"updated-by":[{"DOI":"10.1186\/s12871-021-01390-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000}}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-021-01373-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-021-01373-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-021-01373-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T12:03:47Z","timestamp":1627646627000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-021-01373-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1373"],"URL":"https:\/\/doi.org\/10.1186\/s12871-021-01373-y","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"assertion":[{"value":"5 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12871-021-01390-x","URL":"https:\/\/doi.org\/10.1186\/s12871-021-01390-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Clinical Research Ethics Committee of Mengcheng County No. 1 People\u2019s Hospital (2020MYL20003) and registered at\n                      \n                      (15\/09\/2020, ChiCTR-2000038252). The study protocol followed the CONSORT guidelines. The study protocol was performed in the relevant guidelines. Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}